| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 95 |
| 1 | NIVOLUMAB | 91 |
| 2 | IPILIMUMAB | 54 |
| 3 | CARBOPLATIN | 36 |
| 4 | HYDROCORTISONE | 30 |
| 5 | HYDROCORTISONE ACETATE | 27 |
| 6 | ANTI ITCH | 26 |
| 7 | ANTI-ITCH | 26 |
| 8 | ANTI-ITCH CREAM | 26 |
| 9 | ANTI-PRURITIC | 26 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | METYRAPONE | 7 | 0.0070 |
| 1 | MEFENAMIC ACID | 6 | 0.0027 |
| 2 | BEPOTASTINE BESILATE | 1 | 0.0016 |
| 3 | TREMELIMUMAB | 6 | 0.0014 |
| 4 | OSILODROSTAT | 3 | 0.0014 |
| 5 | IPILIMUMAB | 54 | 0.0012 |
| 6 | CHLORPROMAZINE HYDROCHLORIDE | 1 | 0.0010 |
| 7 | MIFEPRISTONE | 5 | 0.0010 |
| 8 | AMINOPHYLLINE | 2 | 0.0010 |
| 9 | ATAZANAVIR | 14 | 0.0010 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adrenal Steroid Synthesis Inhibitor [EPC] | 7 | 0.0070 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 199 | 0.0020 |
| 2 | CTLA-4-directed Blocking Antibody [EPC] | 60 | 0.0012 |
| 3 | Progestin Antagonist [EPC] | 5 | 0.0010 |
| 4 | Protease Inhibitor [EPC] | 23 | 0.0005 |
| 5 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 3 | 0.0005 |
| 6 | Somatostatin Analog [EPC] | 3 | 0.0004 |
| 7 | Programmed Death Ligand-1 Blocker [EPC] | 9 | 0.0004 |
| 8 | Ergot Derivative [EPC] | 2 | 0.0004 |
| 9 | Cytochrome P450 3A Inhibitor [EPC] | 24 | 0.0004 |